Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Recommendations for managing infections in patients with myeloma treated with bispecifics

Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, discusses recommended approaches to monitor and treat infections in patients with multiple myeloma treated with bispecific T-cell engagers (BiTEs). Dr Raje also discusses which prophylaxis regimens should be used for these patients. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.